• September 2009

On September 23, 2009 at 12:00pm PDT, Imaging3’s CEO Dean Janes hosted a State of the Company conference call.

Due to extraordinarily high call volume, the capacity limits of the call were exceeded. During the call, Mr. Janes announced that the latest submission of images to the FDA will take place on Wednesday, September 30, 2009. The statement was followed by a question and answer session in which Mr. Janes took the opportunity to answer questions from callers. The conference call will be available on the company’s website as soon as possible following the conference call.

If you have any questions, please feel free to contact me by e-mail or directly by calling (800) 900-9729.

Sincerely,

Mike Nessen
Vice President Business Development
Imaging3, Inc.
Burbank CA 91505
(800) 900-9729
mike@imaging3.com
www.imaging3.com



Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.